Benjamin Shapiro insider trades

Open-market stock purchases and sales by Benjamin Shapiro, Director at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since May 1, 2023.

Recent trades

DateStockTradeValue
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—

Companies traded

  • ORMP Oramed Pharmaceuticals Inc: other filings, last Dec 31, 2025

Get free alerts when Benjamin Shapiro files a new trade →